These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31519268)

  • 1. The effectiveness of self-directed medical cannabis treatment for pain.
    Li X; Vigil JM; Stith SS; Brockelman F; Keeling K; Hall B
    Complement Ther Med; 2019 Oct; 46():123-130. PubMed ID: 31519268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association between Cannabis Product Characteristics and Symptom Relief.
    Stith SS; Vigil JM; Brockelman F; Keeling K; Hall B
    Sci Rep; 2019 Feb; 9(1):2712. PubMed ID: 30804402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effectiveness of
    Li X; Diviant JP; Stith SS; Brockelman F; Keeling K; Hall B; Vigil JM
    Yale J Biol Med; 2020 Jun; 93(2):251-264. PubMed ID: 32607086
    [No Abstract]   [Full Text] [Related]  

  • 4. Alleviative effects of Cannabis flower on migraine and headache.
    Stith SS; Diviant JP; Brockelman F; Keeling K; Hall B; Lucern S; Vigil JM
    J Integr Med; 2020 Sep; 18(5):416-424. PubMed ID: 32758396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrahydrocannabinol and Cannabidiol Use in an Outpatient Palliative Medicine Population.
    Highet BH; Lesser ER; Johnson PW; Kaur JS
    Am J Hosp Palliat Care; 2020 Aug; 37(8):589-593. PubMed ID: 31986898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis and cannabinoids.
    Med Lett Drugs Ther; 2016 Aug; 58(1500):97-8. PubMed ID: 27466748
    [No Abstract]   [Full Text] [Related]  

  • 7. The Effectiveness of Common Cannabis Products for Treatment of Nausea.
    Stith SS; Li X; Orozco J; Lopez V; Brockelman F; Keeling K; Hall B; Vigil JM
    J Clin Gastroenterol; 2022 Apr; 56(4):331-338. PubMed ID: 35258504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of inhaled Cannabis flower for the treatment of agitation/irritability, anxiety, and common stress.
    Stith SS; Li X; Diviant JP; Brockelman FC; Keeling KS; Hall B; Vigil JM
    J Cannabis Res; 2020 Dec; 2(1):47. PubMed ID: 33526145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical use of cannabis products: Lessons to be learned from Israel and Canada.
    Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA
    Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Use of Δ9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil.
    Morini L; Porro G; Liso M; Groppi A
    Curr Pharm Biotechnol; 2017; 18(10):828-833. PubMed ID: 29189144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.
    Fedorova EV; Wong CF; Ataiants J; Iverson E; Conn BM; Lankenau SE
    Drug Alcohol Depend; 2021 Apr; 221():108648. PubMed ID: 33676073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Raw, Natural Medical
    Vigil JM; Stith SS; Diviant JP; Brockelman F; Keeling K; Hall B
    Medicines (Basel); 2018 Jul; 5(3):. PubMed ID: 29997343
    [No Abstract]   [Full Text] [Related]  

  • 14. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
    Mead A
    Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrahydrocannabinol - friend or foe? - Debate.
    Temple LM; Leikin JB
    Clin Toxicol (Phila); 2020 Feb; 58(2):75-81. PubMed ID: 31062643
    [No Abstract]   [Full Text] [Related]  

  • 16. A primer on medicinal cannabis safety and potential adverse effects.
    Arnold JC
    Aust J Gen Pract; 2021 Jun; 50(6):345-350. PubMed ID: 34059837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical uses of cannabis and cannabinoids in the United States.
    Levinsohn EA; Hill KP
    J Neurol Sci; 2020 Apr; 411():116717. PubMed ID: 32044684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication overuse headache in patients with chronic migraine using cannabis: A case-referent study.
    Zhang N; Woldeamanuel YW
    Headache; 2021 Sep; 61(8):1234-1244. PubMed ID: 34370866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences exist in the perceived relief of cancer symptoms with medical cannabis: results from the Quebec Cannabis Registry.
    Kasvis P; Canac-Marquis M; Aprikian S; Vigano M; Vigano A
    Support Care Cancer; 2022 Oct; 30(10):7863-7871. PubMed ID: 35723729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Authorization Patterns, Safety, and Effectiveness of Medical Cannabis in Quebec.
    Kalaba M; MacNair L; Peters EN; Eglit GML; Rapin L; Hage CE; Prosk E; Ware MA
    Cannabis Cannabinoid Res; 2021 Dec; 6(6):564-572. PubMed ID: 33998902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.